Harnessing the Fcμ Receptor for Potent and Selective Cytotoxic Therapy of Chronic Lymphocytic LeukemiaPublished in Cancer Research, 2014Download this paper from the journal or PubMed.See more at my Google Scholar page.Share on Twitter Facebook Google+ LinkedIn Previous Next
